Advertisement

PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 15–15 | Cite as

Elbasvir/grazoprevir cost saving for hepatitis C GT1

Clinical study

Reference

  1. Corman S, et al. Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection. Value in Health : 20 Jun 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.05.003

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations